Chylous Ascites as a Possible Rare Side Effect of Selpercatinib in RET-Positive NSCLC
- PMID: 36682840
- DOI: 10.1016/j.jtho.2022.10.012
Chylous Ascites as a Possible Rare Side Effect of Selpercatinib in RET-Positive NSCLC
Comment on
-
Brief Report: Chylothorax and Chylous Ascites During RET Tyrosine Kinase Inhibitor Therapy.J Thorac Oncol. 2022 Sep;17(9):1130-1136. doi: 10.1016/j.jtho.2022.06.008. Epub 2022 Jul 2. J Thorac Oncol. 2022. PMID: 35788405 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical